Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
Zhenfang Du(Chinese University of Hong Kong), Christine M. Lovly(Vanderbilt University)
Cited by 70
Related Papers
Mechanisms of receptor tyrosine kinase activation in cancer
|Molecular Cancer|2018|1.1k
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
|PLoS ONE|2012|203
Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors
|Modern Pathology|2015|107
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation
|Oncotarget|2016|28
Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3